PI
BMRN icon

Placemark Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Placemark Investments’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$764K Sell
8,474
-351
-4% -$29.2K 0.01% 1005
2014
Q3 		$637K Sell
8,825
-827
-9% -$54.3K 0.01% 1076
2014
Q2 		$600K Buy
9,652
+2,791
+41% +$169K 0.01% 1107
2014
Q1 		$469K Buy
+6,861
New +$506K 0.01% 1156

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Placemark Investments's BMRN Position: Q4 2014 in Review

Placemark Investments reduced its BioMarin Pharmaceuticals (BMRN) stake by 4% in Q4 2014, selling an estimated $29.2K and leaving 8,474 shares worth $764K. The position accounts for 0.01% of the portfolio, ranked #1005.

Placemark Investments first reported a position in BMRN in Q1 2014 and has held it in 4 quarters since. 341 funds tracked by Wall St. Rank hold BMRN as of Q4 2014.

  • Placemark Investments held 8,474 shares of BioMarin Pharmaceuticals worth $764K as of Q4 2014.
  • Placemark Investments sold 351 BioMarin Pharmaceuticals shares in Q4 2014, an estimated $29.2K.
  • BioMarin Pharmaceuticals made up 0.01% of Placemark Investments's portfolio in Q4 2014, its #1005 holding.
  • Placemark Investments first reported a position in BioMarin Pharmaceuticals in Q1 2014 and has held it in 4 quarters since.
  • 341 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.